Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring system
Authors:
- Robert O. HughesRHRobert O. Hughes
- John K. WalkerJWJohn K. Walker
- Jerry W. CubbageJCJerry W. Cubbage
- Yvette M. FobianYFYvette M. Fobian
- D. Joseph RogierDRD. Joseph Rogier
- Steve E. HeasleySHSteve E. Heasley
- Rhadika M. Blevis-BalRBRhadika M. Blevis-Bal
- Alan G. BensonABAlan G. Benson
- Dafydd R. OwenDODafydd R. Owen
- E. Jon JacobsenEJE. Jon Jacobsen
- John N. FreskosJFJohn N. Freskos
- John M. MolyneauxJMJohn M. Molyneaux
- 1 August 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (15) , 4092-4096
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitorsBioorganic & Medicinal Chemistry Letters, 2009
- Theoretical Study on the Complexes of Benzene with Isoelectronic Nitrogen‐Containing HeterocyclesChemphyschem, 2008
- Medicinal Chemistry of hERG Optimizations: Highlights and Hang-UpsJournal of Medicinal Chemistry, 2006
- Chapter 6. Phosphodiesterase 5 inhibitors2002
- Cyclic GMP Phosphodiesterase-5: Target of SildenafilJournal of Biological Chemistry, 1999
- Cyclic nucleotide phosphodiesterases: functional implications of multiple isoformsPhysiological Reviews, 1995